Forensic expert evaluation problems of early and late complications of interventional methods of treating coronary heart disease (systematic literature review)
https://doi.org/10.18087/cardio.2021.5.n1003
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
This article focuses on current concepts of ischemic heart disease, its interventional treatment, pathomorphology of early and late postoperative complications, and forensic aspects in evaluation of restenosis of a stented blood vessel.
About the Authors
I. A. KolomoetsRussian Federation
Assistant, Department of Forensic Medicine
S. S. Todorov
Russian Federation
Head of the department, morphological department of the clinic RostSMU
R. V. Sidorov
Russian Federation
Associate Professor, Department of Surgical Diseases №2
S. S. Bachurin
Russian Federation
Senior Lecturer, Department of General and Clinical Biochemistry N 2
D. P. Berezovskii
Russian Federation
Professor, Department of Forensic Medicine
References
1. Shalnova S.A., Oganov R.G., Steg F.G., Ford J. Coronary heart disease. Modern reality according to the CLARIFY World Register. Cardiology. 2013; 53(8): 28-33
2. Bokeria L.A., Gudkova R.G. Cardiovascular Surgery - 2010. Diseases and congenital malformations of the circulatory system. -M.: A.N. Bakoulev SCCS RAMS;2011. - 192 p. ISBN 978-5-7982-0290-4
3. Bokeriya L.A., Pirtskhalaishvili Z.K., Sigaev I.Yu., Danish N.A., Serguladze T.N. Modern approaches to the diagnosis and surgical treatment of brachiocephalic arteries in patients with coronary heart disease. Annals of the Russian Academy of Medical Sciences. 2012;67(10):4-11.
4. Raggi P. [Coronary artery calcium: pathogenesis and cardiovascular risk]. Giornale Italiano di Cardiologia (Rome). 2019; 20(7): 401-408. https://doi.org/10.1714/3190.31683. [Article in Italian]
5. Moreyra E. Jr., Lorenzatti D., Moreyra C., Arias V., Tibaldi M.A., Lepori A.J., et al. [Comparison of risk scores to predict subclinical atherosclerosis]. Medicina (B Aires). 2019;79(5):373-383. PMID: 31671387 [Article in Spanish]
6. Priori S. Task Force on Sudden Cardiac Death of the European Society of Cardiology. European Heart Journal. 2001; 22(16):1374-1450. https://doi.org/10.1053/euhj.2001.2824.
7. Fishman G.I., Chugh S.S., Di Marco J.P., Albert C.M., Anderson M.E., Bonow R.O., et al. Sudden cardiac death prediction and prevention: report from a national heart, lung, and blood institute and heart rhythm society workshop. Circulation. 2010; 122(22): 2335-2348. https://doi.org/10.1161/circulationaha.110.976092.
8. ACC/AHA/ESC 2006. Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death - Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(10):1088-1132. https://doi.org/10.1161/circulationaha.106.178104.
9. Panidis I., Joel M. Sudden death in hospitalized patients: Cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring. J Am CollCardiol. 1983;2(5):798-805. https://doi.org/10.1016/s0735-1097(83)80225-3.
10. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart Disease and Stroke Statistics--2012. Update: A Report From the American Heart Association. Circulation. 2011;125(1): e2-e220. https://doi.org/10.1161/cir.0b013e31823ac046
11. Gillum R. Sudden coronary death in the United States: 1980-1985. Circulation. 1989;79(4):756-765. https://doi.org/10.1161/01.cir.79.4.756.
12. Heidenreich P.A., Trogdon J.G., Khavjou O.A., Butler J., Dracup K., Ezekowitz M.D., et al. Forecasting the future of cardiovascular disease in the united states a policy statement from the American heartassociation. Circulation. 2011; 123:933-944. https://doi.org/10.1161/cir.0b013e31820a55f5
13. Glyantsev S.P. Phenomenon of Demikhov. In the Vishnevsky Institute of Surgery (1947-1955): Development mammaro coronary anastomosis (1952-1953). Organ transplantation in the light of the Michurin theory (1953). Transplantology. 2015;2:39-48.
14. Burakovskiy V.I., Bokeria L.A. Cardiovascular surgery. Guide. -M.: Medicine;1989. - 752 p. ISBN 5-225-0677-9
15. Fioranelli M., Roccia M.G., Rovesti M. et al. René Favaloro: the heart surgeon. Wien Med Wochenschr. 2017;167:25-26 https://doi.org/doi.org/10.1007/s10354-017-0586-y.
16. Gruentzig A.R. Transluminal dilatation of coronary-artery stenosis [letter to the editor]. Lancet. 1978; 1: 263.
17. Sigwart U., Puel J., Mirkovitch V., Joffre F., Kappenberger L., Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty, N. Engl. J. Med.1987;316: 701-706. https://doi.org/10.1056/NEJM19870319316120116.
18. Seyidov V.G., Evsukov V.V., Lyubchuk I.V., Matveev O.N., Bobyrev S.E., Akimenko V.B. Long-term results of angioplasty and stenting of coronary arteries in patients with coronary heart disease. Pacific Medical Journal. 2006;1(23):5-10.
19. Glazier J.J., Varricchione T.R., Ryan T.J., Ruocco N.A., Jacobs A.K., Faxon D.P. Factors predicting recurrent restenosis after percutaneous transluminal coronary balloon angioplasty. Am J Cardiol. 1989;63:902-5. https://doi.org/10.1016/0002-9149(89)90136-7
20. Waller B.F., Pinkerton C.A., Orr C.M., Slack J.D., Van Tassel J.W., Peters T. Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: a necropsy study of 20 patients. J Am Coll Cardiol. 1991; 17:58B-70B. https://doi.org/10.1016/0735-1097(91)90940-b
21. Berezovskii D.P., Gribennikov S.N., Dodohova M.A. Thrombosis In Forensic Medicine. Medical Bulletin of the North Caucasus. 2011;1:79-82.
22. Osiev A.G., Mironenko S.P., Elkina D.S., Koleda N.V., Krestyaninov O.V., Kretov E.I. et al. Comparative clinical-angiographic evaluation of longterm results of coronary stenting in patients with coronary artery disease using drug-sents a different cover. Circulatory pathology and cardiac surgery. 2012;16(2):45-51.
23. Majlyan D.E., Afanasyev Yu.I., Gagarina D.O., Majlyan E.A. The current state of the problem of in-stent restenosis. Scientific reports of Belgorod State University. Series: Medicine. Pharmacy. 2015;10(207):5-12.
24. Iskhakov M.M., Tagirova D.R., Gazizov N.V., Nugaybekova L.A., Sayfutdinov R.G. «No-reflow» phenomenon: clinical aspects of reperfusion failure. Kazan medical journal. 2015;96(3):391-6. https://doi.org/10.17750/KMJ2015-391
25. Shiryaeva Yu.N., Kuzmin D.A., Seleznev S.V., Antonenko A.O. No-reflow syndrome, or what may be dangerous percutaneous coronary intervention. Collection of clinical cases. Materials of the scientificpractical conference. 2017;244-7.
26. Artemyev V.V., Ishmetov V.Sh. Iatrogenic dissection of the left coronary artery. Clinical case. Creative Surgery and Oncology. 2017;7(2):67-72. https://doi.org/10.24060/2076-3093-2017-7-2-67-72
27. Laskey W.K., Williams D.O., Vlachos H.A., Cohen H., Holmes D.R., King III S.B., et al. Changes in the practice of percutaneous coronary intervention: a comparison of enrollment waves in the national heart, lung, and blood institute (NHLBI) dynamic registry. Am J Cardiol. 2001;87(8):964-9. https://doi.org/10.1016/S0002-9149(01)01430-8.
28. Khameneh-Bagheri R., Jafarzadeh-Esfehani R., Ahmadi M. Septal hematoma due to stent implementation in the septal course of the left anterior descending artery. ARYA Atheroscler. 2017;13(5):253-256.
29. Vlasov V.Yu. Perforation of a branch of a blunt margin with the development of hemotamponade and subsequent dislocation of the stent from a balloon catheter in the envelope of the branch. 2016;92-6.
30. Claessen B.E., Henriques J.P., Jaffer F.A., Mehran R., Piek J.J., Dangas G.D. Stent thrombosis. JACC Cardiovasc Interv. 2014; 7:1081-92. https://doi.org/10.1016/j.jcin.2014.05.016
31. Popova A.A., Berezikova E.N., Mayanskaya S.D. Mechanism of endothelial dysfunction development. Siberian Medical Review. 2010;4(64):7-11.
32. Baktashian M., Soflaei S., Kosari N., Salehi M., Khosravi A., Ahmadinejad M., et al. Association of high level of Hs-CRP with in-stent restenosis: A case-control study. Cardiovasc Revasc Med. 2018; 20(7): 583-587 https://doi.org/10.1016/j.carrev.2018.08.015.
33. Goloshchapov-Aksenov R.S., Ternovyh M.V., Lebedev A.V., Levchenko A.E., Merkulov E.V., Mirzonov V.A. The use of a filter conductor for the prevention of the no-reflow phenomenon in endovascular revascularization of the coronary arteries in a patient with acute myocardial infarction. Diagnostic and interventional radiology. 2012;6(3):73-80.
34. Carrick D., Oldroyd K.G., McEntegart M., Haig C., Petrie M.C., Eteiba H., et al. A Randomized Trial of Deferred Stenting versus Immediate Stenting to Prevent No-or Slow Reflow in Acute ST-Elevation Myocardial Infarction (DEFERSTEMI).J Am Coll Cardiol. 2014; 63:2088-2098. https://doi.org/10.1016/j.jacc.2014.02.530
35. Zhang M., Cresswell N., Tavora F., Mont E., Zhao Z., Burke A. Instent restenosis is associated with neointimal angiogenesis and macrophage infiltrates. Pathol Res Pract. 2014; 210(12):1026-30. https://doi.org/10.1016/j.prp.2014.04.004.
36. Stettler C., Wandel S., Allemann S., Kastrati A., Morice M.C., Schömig A., et al. Outcomes associated with drug-eluting and baremetal stents: a collaborative network meta-analysis. Lancet. 2007; 370:937-48. https://doi.org/10.1016/s0140-6736(07)61444-5
37. Al Suwaidi J., Berger P.B., Holmes D.R. Jr. Coronary artery stents. JAMA 2000; 284:1828-36. https://doi.org/10.1001/jama.284.14.1828
38. Ruygrok P.N., Ormiston J.A., O’Shaughnessy B. Coronary angioplasty in New Zealand 1995-1998: a report from the National Coronary Angioplasty Registry. N Z Med J. 2000; 113:381-4.
39. Kuznetsov K.A., Kharkova M.V., Karpenko A.A., Laktionov P.P. Vascular stents: Approaches used to increase their clinical efficacy. Angiology and vascular surgery. 2018;24(2):69-79.
40. Speck U., Scheller B., Hamm B. Drug-coated balloons for restenosis prophylaxis. RoFo. 2014; 186(4):348-358. https://doi.org/10.1055/s-0033-1350523.
41. Pigolkin Yu.I., Nikityuk D.B., Asanov A.Yu., Berezovskii D.P., Bachurin S.S., Sas’ko S.S. Model of Moderate Hyperhomocisteinemia Associated with Mechanical Injury: Dynamics of Morphometric Parameters of Microcirculatory Vessels. Bulletin of Experimental Biology and Medicine. 2019;167(4):525-8.
42. Kawano H., Inoue K., Matsumoto Y., Sato O., Arakawa S., Nakatomi D., et al. Calcification around the Struts of a Sirolimus-eluting Stent Approximately 16 Months after Implantation in an Autopsy Case. Intern Med. 2016; 55(4):353-8. https://doi.org/10.2169/internalmedicine.55.4799.2016.
43. Elbadawi A., Saad M., Elgendy I.Y., Zafar A., Chow M.Y. Multiple myocardial abscesses secondary to late stent infection. Cardiovasc Pathol. 2017; 28:1-2. https://doi.org/10.1016/j.carpath.2017.01.007.
44. Mont E., Cresswell N., Burke A. Pathologic findings of coronary stents: a comparison of sudden coronary death versus non-cardiac death. J Forensic Sci. 2013; https://doi.org/):1542-8.doi: 10.1111/1556-4029.12285.
45. Mollichelli N., Morici N., Ambrogi F., Latib A., Boracchi P., Godino C., et al. Prolonged double antiplatelet therapy in a cohort of “de novo” diabetic patients treated with drug-eluting stent implantation. Am J Cardiol. 2010; 105:1395-401. https://doi.org/10.1016/j.amjcard.2009.12.062
46. Töro K., Kiss M., Szarvas V., Nemeskéri A., Kristóf I., Magyar L. et al. Postmortem introduction of corrosion cast method after coronary stent implantation. Forensic Sci Int. https://doi.org/;171(2-3):208-11.doi: 10.1016/j.forsciint.2007.02.017
47. Törő K., Matlakovics B., Dudás I., Karlinger K., Kiss M., Molnár A., et al. The utility of the combination of the corrosion cast method and postmortem MSCT scans. Leg Med (Tokyo). 2014. (5):283-9. https://doi.org/10.1016/j.legalmed.2014.06.004.
48. Welten S.M.J., de Jong R.C.M., Wezel A., de Vries M.R., Boonstra M.C., Parma L., et al. Inhibition of 14q32 microRNA miR-495 reduces lesion formation, intimal hyperplasia and plasma cholesterol levels in experimental restenosis. Atherosclerosis.2017;261:26-36. https://doi.org/10.1016/j.atherosclerosis.2017.04.011.
49. Schulz C., Herrmann R.A., Beilharz C., Pasquantonio J., Alt E. Coronary stent symmetry and vascular injury determine experimental restenosis. Heart.2000;83(4):462-7. https://doi.org/10.1136/heart.83.4.462
50. Kubo T., Maehara A., Mintz G.S., Garcia-Garcia H.M., Serruys P.W., Suzuki T., et al. Analysis of the long-term effects of drug eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound. Am Heart J. 2010; 159(2):271-7. https://doi.org/10.1016/j.ahj.2009.11.008.
Review
For citations:
Kolomoets I.A., Todorov S.S., Sidorov R.V., Bachurin S.S., Berezovskii D.P. Forensic expert evaluation problems of early and late complications of interventional methods of treating coronary heart disease (systematic literature review). Kardiologiia. 2021;61(5):82-88. (In Russ.) https://doi.org/10.18087/cardio.2021.5.n1003
ISSN 2412-5660 (Online)